TG Therapeutics (TGTX) Plans Conf. Call for GENUINE Phase 3 Update
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
TG Therapeutics, Inc. (Nasdaq: TGTX), announced that a conference call will be held tomorrow, Thursday, October 13, 2016 at 8:30am ET to provide an update on the GENUINE Phase 3 Trial. Michael S. Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.
In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics GENUINE Update Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at www.tgtherapeutics.com. An audio recording of the conference call will also be available for replay at www.tgtherapeutics.com, for a period of 30 days after the call.
TG Therapeutics will announce details of the amendments in a press release to be issued prior to the call.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla (TSLA) Posts Q3 adj.-EPS of 71c
- Minerva Neurosciences (NERV) Reports Six-Month Data from Phase IIb Trial of MIN-10 in Schizophrenia
- Agilysys, Inc. (AGYS) Plans CEO Search; CFO Seebeck Resigns
Create E-mail Alert Related CategoriesConference Calls, Corporate News
Related EntitiesDefinitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!